🔗 Visit the ClinicalTrials.gov page for NCT00836888
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Antagonist antibodies to PD-1 and B7-H1 (PD-L1) in the treatment of advanced human cancer. | Clin Cancer Res | 2013 | 3.48 |
| 2 | The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma. | Clin Ther | 2015 | 1.73 |
| 3 | Cancer immunotherapy in clinical practice -- the past, present, and future. | Chin J Cancer | 2014 | 0.98 |
| 4 | Immunotherapy for advanced gastric and esophageal cancer: preclinical rationale and ongoing clinical investigations. | J Gastrointest Oncol | 2015 | 0.89 |
| 5 | Enhancement of dendritic cells as vaccines for cancer. | Immunotherapy | 2010 | 0.86 |
| 6 | PD-1 and PD-L1 antibodies for melanoma. | Hum Vaccin Immunother | 2014 | 0.80 |
| 7 | Immune Checkpoint Modulation in Colorectal Cancer: What's New and What to Expect. | J Immunol Res | 2015 | 0.78 |